| 摘要: |
| 目的 吲哚胺2,3-双加氧酶1(Indoleamine-2,3-dioxygenase 1,IDO1)催化色氨酸的氧化裂解,是色氨酸-犬尿氨酸途径中的关键限速步骤。在肿瘤组织中,肿瘤细胞高表达吲哚胺2,3-双加氧酶1,因此设计其小分子抑制剂有望成为有效的肿瘤免疫治疗药物。方法 本研究在前期高通量筛选发现的先导化合物LVS-19的基础上,通过分子对接模型,设计合成新型吲哚胺-2,3-双加氧酶1抑制剂。结果 设计并合成5个衍生物。其中最优化合物6e测得的IC50值为2.61 μmol·L-1,相较于苗头化合物活性提高约3倍的。结论 本研究能为吲哚胺2,3-双加氧酶1抑制剂的结构修饰与改造提供理论依据。 |
| 关键词: 吲哚胺-2,3-双加氧酶1 吲哚胺-2,3-双加氧酶1抑制剂 免疫逃逸 设计及与活性研究 |
| DOI:10.13506/j.cnki.jpr.2022.05.001 |
| 基金项目:国家自然科学基金青年基金(No.81703347) |
|
出版日期:2022-05-25
|
|
| Design, synthesis and biological evaluation of novel indoleamine 2,3-dioxygenase 1 inhibitors |
| YU Jiankang1,ZHOU Liang1,GONG Yinhua1,BIAN Jinlei2 |
| (1.The First Affiliated Hospital of Soochow University,Suzhou 215006,China; 2.China Pharmaceutical University, Nanjing 211198,China) |
| Abstract: |
| Objective Indoleamine-2,3-dioxygenase 1 (IDO1) catalyzes the oxidative cleavage of tryptophan, which is the first and rate-limiting step in the kynurenine pathway of tryptophan catabolism in mammalian cells. IDO1 is widely expressed in tumor cells, its inhibitors would be a potential cancer immunotherapy drug.Methods With the aim of discovering novel IDO1 inhibitors, a series of novel compounds were designed and synthesized based on our previous reported lead compound LVS-019. Results 5 derivatives were designed and synthesized. Among them, the IC50 value measured by the optimized compound 6E was 2.61 μmol·L-1, which was about 3 times compared to the active activity of the signs. Conclusion These synthetic cyano-based IDO1 inhibitors were expected to provide a theoretical basis for the structural modification of IDO1 inhibitors. |
| Key words: Indoleamine-2,3-dioxygenase 1 IDO1 inhibitors Immune escape Design and biological evaluation |